Skip to content
Disability, Medical Health Aged Care

GeneEQUAL: a model of inclusive health care for people with intellectual disability

UNSW Sydney 5 mins read
Dr Emma Palmer, Skie Sarfaraz and Professor Iva Strnadovu00e1 while filming the GeneEQUAL videos highlighting effective communication in genetic health-care appointments. Photo: Supplied.

Receiving genetic health care can be a challenging, isolating experience for many people with intellectual disability. Meet the UNSW researchers who are trying to change that.  

Imagine walking into an appointment with your doctor. The reason for the appointment is never made clear to you. Your doctor never speaks to you directly, preferring to address the person accompanying you. Major decisions about your care are made without your input because you are not considered capable of giving informed consent.  

This is the reality for many Australians with intellectual disability when they receive genetic health care – counselling and information for those who have or are at an increased chance of genetic conditions.  

A team of researchers from UNSW Sydney – led by Dr Emma Palmer, Professor Iva Strnadová and Julie Loblinzk OAM – are taking action to change this reality. Their GeneEQUAL project, a partnership with NSW Health, brings together researchers, people with intellectual disability, and practitioners across health and education. Together, they are creating an inclusive, respectful model of genetic health care.  

Genetic health care is a particularly important aspect of health care for people with intellectual disability. Clarifying the underlying genetic cause for an individual’s intellectual disability, or other conditions they may have such as a predisposition to cancer, can improve their health care outcomes through targeted health checks and therapies, empowerment and reproductive choice.  

Gaps in genetic health care system 

Dr Palmer, who is a clinical geneticist and academic at Sydney Children’s Hospital Network (SCHN) and UNSW Medicine & Health, has seen the challenges people with intellectual disability have faced when receiving genetic counselling.  

“Often they were excluded from the clinical appointments. The person they went with, a parent or support person, was talked at, not them. The language that was used was often very negative and stigmatising,” Dr Palmer says.  

In 2019, Dr Palmer approached Prof. Strnadová and Julie Loblinzk, academics from UNSW's Disability Innovation Institute and School of Education who collaborate on projects to improve the wellbeing of people with intellectual disability. Ms Loblinzk is a self-advocate with lived experience of intellectual disability, who has spent more than 25 years supporting others with intellectual disability to advocate for themselves and live life to the full.  

Dr Palmer’s question was, how can we make genetic health care better for people with intellectual disability? The researchers embarked upon the GeneEQUAL project, and the first step was talking with people with intellectual disability and their families who had experienced genetic health care. 

“Our interviews painted a sad picture – that there was a lack of accessibility, a lack of clear communication, and damaging language was used,” Prof. Strnadová says. 

“There were words like retardation, disorder, mutation… If you keep on hearing these things about yourself, no wonder you don’t have very high self-esteem.” 

Another issue was the assumption that people with intellectual disability can’t provide informed consent for health care decisions. Health care providers would discuss these decisions with the parent or the guardian, ignoring the patient during the consultation.   

“Most people with intellectual disability can provide informed consent and make decisions about their health, as long as the relevant information is made accessible to them,” Prof. Strnadová says.  

The researchers brought these initial findings to NSW Health, who provided funding support to continue the GeneEQUAL study and create a toolkit to educate health care workers, people with intellectual disability, and others involved in their care.  

Co-design research 

To create the GeneEQUAL toolkit, the GeneEQUAL inclusive research team of academic researchers and researchers with intellectual disability worked closely with groups of people with intellectual disability. This process, called co-design, is when stakeholders are actively involved in researching the issue and creating solutions.  

“We took the [initial resources] to Self Advocacy Sydney and other self-advocacy groups. One of the things they love to do is give feedback. And it’s not just one consultation session with them. They always want to come back and have a say,” Ms Loblinzk says. 

According to the researchers, co-design was crucial to creating resources that were accessible and addressed the important issues in genetic health care. They also conducted the research inclusively, for example creating meeting agendas and notes in Easy Read, so that all members of the team could participate fully.  

“We would never have developed the GeneEQUAL toolkit without the members of our team who have intellectual disability, and all of the people who were part of the co-production workshops, and the initial interviews,” Prof. Strnadová says. 

“The critical thing at the centre is the voice of people with intellectual disability.” 

Guidelines for better care 

The GeneEQUAL toolkit contains information for health care professionals, as well as people with intellectual disability.  

For clinicians, there are clear guidelines on providing inclusive, person-centred and respectful genetic health care. This involves making reasonable adjustments, ensuring the patient is at the centre of discussions and decisions, and providing trauma-informed care.  

“It’s about changing the whole mindset. I teach my students that we shouldn’t be seeing ourselves as doctors telling the patient what to do – rather part of a partnership. We should speak as we would to a friend or our mum and treat people with respect,” Dr Palmer says.  

The toolkit also includes videos of health care professionals and people with intellectual disability, demonstrating poor practice versus inclusive, person-centred and respectful practice.  

In addition, there are GeneEQUAL Easy Read resources for people with intellectual disability, helping them to educate themselves about genetic health care, advocate for their rights and prepare for their appointments.   

“I would hope that these resources really support patients to get information – and support patients to have a say because it doesn’t happen a great deal,” Ms Loblinzk says.  

The GeneEqual toolkit has been viewed by more than 750 people to date, and while most users are from Australia, people from the US, UK and Canada are also accessing the material.  

“The anecdotal feedback we are receiving is very positive,” Dr Palmer says.  

“We’ve had someone say they think it should be compulsory training, a support person has said they’ve changed how they behave in appointments as a result, and the Easy Read materials and videos have been very well received by both people with intellectual disability and health care professionals.” 

Empowering people with intellectual disability 

Recently, the GeneEQUAL team have received support from the National Health and Medical Research Council (NHMRC) for a 5-year project to expand GeneEQUAL to other Australian states. The researchers will continue the co-design process with people with intellectual disability from across the country.  

GeneEQUAL also provides a model for making services more inclusive for people with intellectual disability, using co-design. The project shows that people with intellectual disability can contribute so much more, and get so much more out of life, if they are given the opportunity.  

“It was really hard growing up. I didn’t have a say in what was happening,” Ms Loblinzk says.  

“I really want people to speak up, have choices, make decisions and be empowered in what they’re doing.”   

Contact details:

Media contact

For enquiries about this story and interview requests please contact Maddie Massy-Westropp, News & Content Coordinator, UNSW Medicine & Health.

Tel: +61 2 9348 1936 


Alternatively, please contact Samantha Dunn, News & Content Coordinator, UNSW Arts, Design & Architecture. 

Tel: + 61 2 9065 5455



More from this category

  • Medical Health Aged Care, Political
  • 08/12/2023
  • 15:35
Health Services Union

Minns ministers must stop misleading on paramedic pay

The Minns government is misleading the public with deliberately inflated figures about what paramedics are paid, as it risks mass resignation and deregistration of one of its most skilled but underpaid workforces.In a note circulated to media, the Government has claimed its pay offer would lift a first year paramedic’s take home pay from $123,594 to $137,683.This is not a figure that has been put to the HSU and nor it accurate. The offer put to the Union proposes a paltry 11.4 per cent, four year increase to the base pay of first year paramedics, from $74,364 to $82,877.The so-called…

  • Medical Health Aged Care, Political
  • 08/12/2023
  • 14:11
Health Equity Matters

Darryl O’Donnell steps down as CEO of Health Equity Matters

Health Equity Matters pays tribute to chief executive officer, Adjunct Professor Darryl O’Donnell, who is stepping down after eight impactful years leading the organisation. Health Equity Matters president, Mark Orr AM, said O’Donnell had been a transformative leader. “Darryl became chief executive at a very challenging time for the organisation. In the years since, he has worked tirelessly to enhance its stability and sustainability. This has expanded our capacity and impact. “Among his many achievements, Darryl has most recently helped shape the work of the HIV Taskforce chaired by the Hon Mark Butler MP, and the LGBTIQA+ Health Ten Year…

  • Medical Health Aged Care
  • 08/12/2023
  • 12:07

EnGeneIC granted FDA “Fast-Track” Designation for Novel Armed Nanocell Drug Conjugate (ANDC) Pancreatic Cancer Therapeutic

SYDNEY, Australia and NEW YORK, Dec. 07, 2023 (GLOBE NEWSWIRE) -- EnGeneIC, an innovative biopharmaceutical company leading the field of armed antibody therapeutics for oncology, has achieved a significant milestone with the granting of FDA “Fast-Track” designation for its pancreatic cancer therapeutic. This approval underscores the potential of EnGeneIC’s unique approach to revolutionise pancreatic cancer treatment.Pancreatic ductal adenocarcinoma (PDAC) is a notoriously challenging and aggressive form of cancer, usually diagnosed in advanced stages, making curative treatment options limited.The FDA’s decision to grant “Fast-Track” status reflects the urgency and unmet medical need associated with PDAC. EnGeneIC’s EDVTM (EnGeneIC Dream Vector) has…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time your distribute with Medianet. Pay per release or save with a subscription.